Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

EPIDEMIOLOGY AND OUTCOME OF DISTAL RADIUS FRACTURES



Abstract

Introduction: We present the world’s largest current series of open distal radial fractures (ODRF), aiming to describe the epidemiology and outcomes of these injuries.

Methods: Patients with ODRF treated at the Edinburgh Orthopaedic Trauma unit between 1990 and 2009 were identified from computer records. All patients aged over 13 with juxta-articular and metaphyseal fractures were included – diaphyseal injuries were excluded. The following information was retrieved from notes and radiographs: patient demographics; co-morbidities; mechanism of injury; AO classification; other injuries; time to A& E treatment; time until surgery; antibiotic use; Gustillo and Anderson (GA) grade; surgical treatment; complications; further surgery; functional outcome.

Results: 201 patients were included. The average age was 65.5 years, 75% were female. 69% resulted from simple falls, 15% falls from height, 6% sporting injuries and 9% from road traffic accidents. 73 % were GA-1, 26% were GA-2, 1% GA-3. The commonest fracture pattern was AO 23-C2. 41% underwent definitive debridement within 6 hours, 46% in 6 to 24 hours, 13% waited longer. 30% were treated by ORIF, 38% with non-bridging fixator, 29% by bridging fixator and 3% by MUA and plaster. 43% of wounds were closed primarily, 47% were left open, 8% required delayed closure, 2% required skin grafting. Follow-up averaged 16.5 weeks. 14% suffered superficial infections, 1.3% suffered deep infection. Predictors of infection included primary closure and the use of an external fixator. Functional outcome was variable.

Discussion: Most open distal radial fractures occur in elderly women after a simple fall. Serious infection rates are low.

Correspondence should be addressed to: EFORT Central Office, Technoparkstrasse 1, CH – 8005 Zürich, Switzerland. Tel: +41 44 448 44 00; Email: office@efort.org

Author: Samuel Molyneux, United Kingdom

E-mail: sgmolyneux@googlemail.com